Inflammatory myopathies in children

Pediatric Clinics of North America

Volumn 52, Issue 2, 2005, Pages 493-520

  Compeyrot Lacassagne, Sandrine ^a   Feldman, Brian M ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; BETA INTERFERON; CD59 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GAMMA INTERFERON; HLA DM ANTIGEN; HLA DQA1 ANTIGEN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INTERCELLULAR ADHESION MOLECULE 1; METHOTREXATE; METHYLPREDNISOLONE; MYOSIN; PREDNISONE; TACROLIMUS; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTERY INTIMA PROLIFERATION; BACILLUS SUBTILIS; BORRELIA BURGDORFERI; CALCINOSIS; CAPILLARY; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; COMPLEMENT SYSTEM; DERMATOMYOSITIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG MEGADOSE; ELECTROMYOGRAM; ENVIRONMENTAL FACTOR; ENZYME ANALYSIS; ESCHERICHIA COLI; GENE FREQUENCY; GENETIC PREDISPOSITION; HAEMOPHILUS INFLUENZAE; HEART DISEASE; HELICOBACTER PYLORI; HIRSUTISM; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INCLUSION BODY MYOSITIS; INFARCTION; LABORATORY TEST; LIPODYSTROPHY; LONG TERM CARE; LUNG DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROCHIMERISM; MUSCLE BIOPSY; MUSCLE FUNCTION; MUSCLE STRENGTH; MYCOPLASMA HOMINIS; MYOSITIS; NEUROLOGICAL COMPLICATION; PATHOGENESIS; POLYMYOSITIS; PROTEIN FUNCTION; QUALITY OF LIFE; REVIEW; SIDE EFFECT; STREPTOCOCCUS PYOGENES; THROMBOSIS; TREATMENT OUTCOME; VASCULAR DISEASE; VASCULITIS;

EID: 16244367167     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2005.01.004     Document Type: Review

References (97)

1. A. Bohan, and J.B. Peter Polymyositis and dermatomyositis [part 1 of 2] N Engl J Med 292 7 1975 34 37
2. B.Q. Banker, and M. Victor Dermatomyositis (systemic angiopathy) of childhood Medicine (Baltimore) 45 4 1966 261 289
3. D.P.M. Symmons, J.A. Sills, and S.M. Davis The incidence of juvenile dermatomyositis: results from a nation-wide study Br J Rheumatol 34 1995 732 736
4. E.P. Mendez, R. Lipton, and R. Ramsey-Goldman US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry Arthritis Rheum 49 3 2003 300 305
5. T.A.J. Medsger, W.N. Dawson, and A.T. Masi The epidemiology of polymyositis Am J Med 48 1970 715 723
6. P. Ang, M.W. Sugeng, and S.H. Chua Classical and amyopathic dermatomyositis seen at the national centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy Ann Acad Med Singapore 29 2 2000 219 223
7. L.M. Pachman Juvenile dermatomyositis: immunogenetics, pathophysiology and disease expression Rheum Dis Clin North Am 28 2002 579 602
8. Cassidy J.T., Petty R.E., editors. Juvenile dermatomyositis. In: Textbook of pediatric rheumatology. 4th edition. p. 465-504
9. A.M. Reed, and J.D. Stirling Association of the HLA-DQA1*0501 allele in multiple racial groups with juvenile dermatomyositis Hum Immunol 44 1995 131 135
10. E.A. Shamim, L.G. Rider, and F.W. Miller Update on the genetics of the idiopathic inflammatory myopathies Curr Opin Rheumatol 12 2000 482 491
11. J.E. West, and A.M. Reed Analysis of HLA-DM polymorphism in juvenile dermatomyositis (JDM) patients Hum Immunol 60 1999 255 258
12. C.M. Artlett, R. Ramos, and S.A. Jiminez Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group Lancet 356 9248 2000 2155 2156
13. C.M. Artlett, F.W. Miller, and L.G. Rider Persistent maternally derived peripheral microchimerism is associated with the juvenile idiopathic inflammatory myopathies Rheumatology (Oxford) 40 11 2001 1279 1284
14. A.M. Reed, Y.J. Picornell, and A. Harwood Chimerism in children with juvenile dermatomyositis Lancet 356 2000 2156 2157
15. A.M. Reed, K. McNallan, and P. Wettstein Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis J Immunol 172 2004 5041 5046
16. C.M. Artlett, T.P. O'Hanlon, and A.M. Lopez HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals Arthritis Rheum 48 9 2003 2567 2572
17. C.L. Verweij, and T.W.J. Huizinga Tumor necrosis factor alpha gene polymorphisms and rheumatic diseases Br J Rheumatol 37 1998 923 929
18. A.G. Wilson, N. de Vries, and F. Pociot An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles J Exp Med 177 1993 557 560
19. A.G. Wilson, J.A. Symons, and T.L. McDowell Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation Proc Natl Acad Sci U S A 94 1997 3195 3199
20. L.M. Pachman, M.R. Liotta-Davis, and D.K. Hong TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications Arthritis Rheum 43 10 2000 2368 2377
21. T.O. Fedczyna, J. Lutz, and L.M. Pachman Expression of TNFalpha by muscle fibers in biopsies from children with untreated juvenile dermatomyositis: association with the TNFalpha-308A allele Clin Immunol 100 2 2001 236 239
22. J. Lutz, K.G. Huwiler, and T. Fedczyna Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNF alpha-308A allele in children with juvenile dermatomyositis Clin Immunol 103 2002 260 263
23. L.G. Rider, and F.W. Miller Classification and treatment of the juvenile idiopathic inflammatory myopathies Rheum Dis Clin North Am 23 3 1997 619 655
24. M. Massa, N. Costouros, and F. Mazzoli Self epitopes shared between human myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis Arthritis Rheum 46 11 2002 3015 3025
25. Z. Tezak, E.P. Hoffman, and J.L. Lutz Gene expression profiling in DQA1*0501 + children with untreated dermatomyositis: a novel model of pathogenesis J Immunol 168 8 2002 4154 4163
26. J.C. Wargula Update on juvenile dermatomyositis: new advances in understanding its etiopathogenesis Curr Opin Rheumatol 15 5 2003 595 601
27. F.G.P. Goncalves, L. Chimelli, and M.E. Sallum Immunohistological analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis J Rheumatol 29 2002 1301 1307
28. A.M. Sallum, S.K. Marie, and A. Wakamatsu Immunohistochemical analysis of adhesion molecule expression on muscle biopsy specimens from patients with juvenile dermatomyositis J Rheumatol 31 4 2004 801 807
29. C.K.C. Li, H. Varsani, and J.L. Holton MHC class I overexpression on muscles in early juvenile dermatomyositis J Rheumatol 31 3 2004 605 609
30. A. Bohan, and J.B. Peter Polymyositis and dermatomyositis [part 2 of 2] N Engl J Med 292 8 1975 403 407
31. B.M. Feldman, M. Reichlin, and R.M. Laxer Clinical significance of specific autoantibodies in juvenile dermatomyositis J Rheumatol 23 10 1996 1794 1797
32. A.B. Kimball, R.M. Summers, and M. Turner Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis Arthritis Rheum 43 8 2000 1866 1873
33. S.M. Maillard, R. Jones, and C. Owens Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis Rheumatology 43 5 2004 603 608
34. L.M. Pachman, J.R. Hayford, and A. Chung Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children J Rheumatol 25 6 1998 1198 1204
35. L.M. Pachman Juvenile dermatomyositis. Pathophysiology and disease expression Pediatr Clin North Am 42 5 1995 1071 1098
36. L.C. Miller, A.F. Michael, and Y. Kim Childhood dermatomyositis: clinical course and long-term follow-up Clin Pediatr 26 1987 561 566
37. S. Tse, S. Lubelsky, and M. Gordon The arthritis of inflammatory childhood myositis syndromes J Rheumatol 28 1 2001 192 197
38. J.R. Hollister The evolution of juvenile dermatomyositis into chronic arthritis Arthritis Rheum 41 Suppl 1998 S203
39. A.V. Ramanan, and B.M. Feldman Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes Rheum Dis Clin North Am 28 4 2002 833 857
40. T.M. Peloro, O.F. Miller, and T.F. Hahn Juvenile dermatomyositis: a retrospective review of a 30-year experience J Am Acad Dermatol 45 1 2001 28 34
41. B. Santmyire-Rosenberger, and E.M. Dugan Skin involvement in dermatomyositis Curr Opin Rheumatol 15 6 2003 714 722
42. F.E. Ghali, L.D. Stein, and J. Fine Gingival telangiectases. An underappreciated physical sign of juvenile dermatomyositis Arch Dermatol 135 1999 1370 1374
43. B.M. Feldman, L.G. Rider, and L. Dugan Nailfold capillaries as indicators of disease activity in juvenile idiopathic inflammatory myopathies (JIIM) Arthritis Rheum 42 9 1999 S181
44. R.L. Smith, J. Sundberg, and E. Shamiyah Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops J Rheumatol 31 8 2004 1644 1649
45. A.V. Ramanan, and B.M. Feldman Clinical outcomes in juvenile dermatomyositis Curr Opin Rheumatol 14 6 2002 658 662
46. M.C. Eddy, R. Leelawattana, and W.H. McAlister Calcinosis universalis complicating juvenile dermatomyositis: resolution during Probenecid therapy J Clin Endocrinol Metab 82 11 1997 3536 3542
47. B.M. Ansell Juvenile dermatomyositis Rheum Dis Clin North Am 17 1991 931 942
48. L.M. Pachman, A.M. Callen, and J. Hayford Juvenile dermatomyositis: decreased calcinosis with intermittent high-dose intravenous methylprednisolone (IV pulse) Arthritis Rheum 37 Suppl 9 1994 S429
49. R.E. Fisler, M.G. Liang, and R.C. Fuhlbrigge Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis J Am Acad Dermatol 47 2002 505 511
50. S.L. Bowyer, C.E. Blane, and D.B. Sullivan Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification J Pediatr 103 1983 882 888
51. C. Huemer, H. Kitson, and P.N. Malleson Lipodystrophy in patients with juvenile dermatomyositis-evaluation of clinical and metabolic abnormalities J Rheumatol 28 3 2001 610 615
52. B. Senior, and S.S. Gellis The syndromes of total lipodystrophy and partial lipodystrophy Pediatrics 33 1964 593 612
53. S. Trapani, G. Camiciottoli, and A. Vierucci Pulmonary involvement in juvenile dermatomyositis: a two-year longitudinal study Rheumatol 40 2001 216 220
54. L.M. Pachman, and N. Cooke Juvenile dermatomyositis: a clinical and immunologic study J Pediatr 96 2 1980 226 234
55. L.G. Rider, F.W. Miller, and I.N. Targoff Myositis specific autoantibodies (MSA) in children: a broadened spectrum of juvenile myositis Arthritis Rheum 36 1993 S258
56. J.D. Fortenberry, and M.L. Shew Fatal Pneumocystis carinii in an adolescent with systemic lupus erythematosus J Adolesc Health Care 10 6 1989 570 572
57. E.F. Elst, S.S.M. Kamphuis, and B.J. Prakken Severe central nervous system involvement in juvenile dermatomyositis J Rheumatol 30 9 2003 2059 2063
58. A.V. Ramanan, S. Sawhney, and K.J. Murray Central nervous system complications in two cases of juvenile onset dermatomyositis Rheumatology (Oxford) 40 11 2001 1293 1298
59. M. Regan, U. Haque, and M. Pomper Central nervous system vasculitis as a complication of refractory dermatomyositis J Rheumatol 28 2001 207 211
60. A.D. Askari, and T.L. Huettner Cardiac abnormalities in polymyositis/dermatomyositis Semin Arthritis Rheum 12 2 1982 208 219
61. C. Jimenez, P.C. Rowe, and D. Keene Cardiac and central nervous system vasculitis in a child with dermatomyositis J Child Neurol 9 3 1994 297 300
62. S. Bitnum, C.W.J. Daeschner, and L.B. Travis Dermatomyositis J Pediatr 64 1964 101 131
63. H.M. Haupt, and G.M. Hutchins The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients Am J Cardiol 50 5 1982 998 1006
64. R.L. Euwer, and R.D. Sontheimer Amyopathic dermatomyositis: a review J Invest Dermatol 100 1 1993 124S 127S
65. S. Plamondon, and P.B. Dent Juvenile amyopathic dermatomyositis: results of a case finding descriptive survey J Rheumatol 27 8 2000 2031 2034
66. R.A. El-Azhary, and S.Y. Pakzad Amyopathic dermatomyositis: retrospective review of 37 cases J Am Acad Dermatol 46 4 2002 560 565
67. A.M. Huber, B.M. Feldman, and R.M. Rennebohm Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies Arthritis Rheum 50 5 2004 1595 1603
68. G. Singh, B.H. Athreya, J.F. Fries, and D.P. Goldsmith Measurement of health status in children with juvenile rheumatoid arthritis Arthritis Rheum 37 1994 1761 1769
69. B.M. Feldman, A. Ayling-Campos, and L. Luy Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire J Rheumatol 22 2 1995 326 331
70. A.M. Huber, J.E. Hicks, and P.A. Lachenbruch Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group J Rheumatol 28 5 2001 1106 1111
71. D.J. Lovell, C.B. Lindsley, and R.M. Rennebohm Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group Arthritis Rheum 42 10 1999 2213 2219
72. R.M. Rennebohm, K. Jones, and A.M. Huber Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale Arthritis Rheum 51 3 2004 365 370
73. N. Ruperto, A. Ravelli, and K.J. Murray Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis Rheumatol 42 2003 1452 1459
74. D.A. Isenberg, E. Allen, and V. Farewell International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial indices in patients with adult onset disease Rheumatol 43 2004 49 54
75. F.W. Miller, L.G. Rider, and Y.L. Chung Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies Rheumatology (Oxford) 40 11 2001 1262 1273
76. R.M. Laxer, L.D. Stein, and R.E. Petty Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis Arthritis Rheum 30 3 1987 328 334
77. A.S. Paller The use of pulse corticosteroid therapy for juvenile dermatomyositis Pediatr Dermatol 13 4 1996 347 348
78. M.S. Klein-Gitelman, T. Waters, and L.M. Pachman The economic impact of intermittent high-dose intravenous versus oral corticosteroid treatment of juvenile dermatomyositis Arthritis Care Res 13 6 2000 360 368
79. M.S. Klein-Gitelman, and L.M. Pachman Intravenous corticosteroids (IV CS): adverse reactions are more variable than expected in children J Rheumatol 25 1998 1995 2002
80. L.C. Miller, B.A. Sisson, and L.B. Tucker Methotrexate treatment of recalcitrant childhood dermatomyositis Arthritis Rheum 35 10 1992 1143 1149
81. S. Al-Mayouf, A. Al-Mazyed, and S. Bahabri Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate Clin Rheumatol 19 2000 138 141
82. Ramanan A., Campbell-Webster N., Tran D., et al. Initial treatment of juvenile dermatomyositis (JDM) using methotrexate (MTX) and aggressively tapered prednisone (PRED). Pediatric Rheumatology Online Journal;1(4):120. Available at http://www.pedrheumonlinejournal.org/July/derm/123.htm. Accessed February 8, 2005
83. S.M. Al-Mayouf, R.M. Laxer, and R. Schneider Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety J Rheumatol 27 10 2000 2498 2503
84. A. Sansome, and V. Dubowitz Intravenous immunoglobulin in juvenile dermatomyositis-four year review of nine cases Arch Dis Child 72 1995 25 28
85. B. Lang, and G. Murphy Treatment of dermatomyositis with intravenous globulin Am J Med 91 1991 169 172
86. M.C. Dalakas, I. Illa, and J.M. Dambrosia A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis N Engl J Med 329 27 1993 1993 2000
87. P. Riley, S.M. Maillard, and L.R. Wedderburn Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety Rheumatol 43 4 2004 491 496
88. J. Heckmatt, N. Hasson, and C. Saunders Cyclosporin in juvenile dermatomyositis Lancet 1989 1063 1066
89. V. Zeller, P. Cohen, and A. Prieur Cyclosporin A therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases J Rheumatol 23 8 1996 1424 1427
90. I. Kobayashi, M. Yamada, and Y. Takahashi Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A Rheumatology (Oxford) 42 2 2003 371 374
91. N.Y. Olson, and C.B. Lindsley Adjunctive use of hydroxychloroquine in childhood dermatomyositis J Rheumatol 16 12 1989 1545 1547
92. T. Yoshimasu, T. Ohtani, and T. Sakamoto Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis Eur J Dermatol 12 2002 50 52
93. C.B. Hollar, and J.L. Jorizzo Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study J Dermatolog Treat 15 1 2004 35 39
94. M. Ueda, R. Makinodan, and M. Matsumura Successful treatment of amyopathic dermatomyositis with topical tacrolimus Br J Dermatol 148 2003 593 611
95. A. Paller, L.F. Eichenfield, and D.Y.M. Leung A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients J Am Acad Dermatol 44 1 Suppl 2001 S47 S57
96. R. Shehata, S. Al-Mayouf, and A. Al-Dalaan Juvenile dermatomyositis: clinical profile and disease course in 25 patients Clin Exp Rheumatol 17 1 1999 115 118
97. A.M. Huber, B. Lang, and C.M.A. LeBlanc Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis Arthritis Rheum 43 3 2000 541 549